Home›People›Jeffrey Collins
JC

Jeffrey Collins

Executive officer at Uvantis Therapeutics.

Executive
Updated Oct 27, 2026·Latest SEC filing Sep 23, 2026·Suggest an edit

About Jeffrey Collins

Jeffrey Collins is an executive officer at Uvantis Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Jeffrey Collins in the role, so the role may have started earlier or lasted longer.

Uvantis Therapeutics, Inc.
Executive officer
2026 · Columbia, MD
Develops microbiome-based treatments for bladder health.

Key Colleagues at Startups

The people Jeffrey Collins works with at each company, as listed on that company's latest Form D.

Uvantis Therapeutics, Inc. · Form D, Sep 23, 2026
JY
EW
Edward Woo
Director
WS
PG
Paul Giannasca
Executive officer

Sources

  1. SECUvantis Therapeutics, Inc. Form D, filed Sep 23, 2026